INVESTMENT IN IMAGION BIOSYSTEMS

6 Months Ended

Jun. 30, 2018

Notes to Financial Statements

NOTE 3. INVESTMENT IN IMAGION BIOSYSTEMS

As of June 30, 2018, the Company owns 64,099,476 shares of Imagion Biosystems (“Imagion”), resulting in a noncontrolling interest of approximately 31% of Imagion’s issued and outstanding common stock. Based upon Imagion’s trading price on June 30, 2018, approximately US$0.033233 per share, the fair value of the Imagion shares was approximately US$2,130,000. During the six months ended June 30, 2018, the Company recorded unrealized losses in its investment of US$3,372,000.